Newsletter
| Promoter: | Hot Shot Stocks | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| MFTH | $5000 | 3917 |
| Max Profit: 15.38 % | Gain at close: 0.00 % |
|
Click here: Medisafe 1 Technologies Corp. MFTH.OBMedisafe 1 Technologies Closes $5 Million Equity Funding AgreementInvestor Managed by Roswell Capital PartnersPress Release Source: Medisafe 1 Technologies Corp. On Thursday April 14, 2011, 7:45 am EDT
JERUSALEM, April 14, 2011 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB:MFTH.ob - News), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has closed an agreement to receive a $5,000,000 equity investment. The $5,000,000 Equity Funding Facility was signed with Centurion Private Equity, LLC ("Centurion"), an institutional investor managed by Roswell Capital Partners, LLC. The closing of the agreement followed Medisafe 1 Technologies' successful passing extensive due diligence by Centurion. Medisafe 1 Technologies intends to use the funding facility to fund ongoing research and development, and to support general corporate purposes. Centurion will be committed to purchase for cash consideration, subject to certain conditions and limitations described in the agreement, up to an aggregate of $5,000,000 of Medisafe 1 Technologies' common stock. Under the Equity Funding Facility, Medisafe 1 Technologies may, at its discretion, periodically sell to Centurion shares of Medisafe 1 Technologies' common stock at a price based upon the market price (as defined in the agreement) of Medisafe 1 Technologies' common stock. "Through this infusion of funding, Medisafe 1 Technologies will be able to advance rapid efforts to commercialize our life saving devices that prevent the incorrect administration of medicines and transfusions," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "Additional capital will enable the ongoing development of worldwide business activities, and the initiation of pilot programs in hospitals and medical clinics across the world." Roswell Capital Partners, LLC is a fund management company focused on private equity investments in small-cap publicly traded securities. Since 1994, its members have served in the Private Equity Markets as the Principal or Investment Banker for over 125 public companies including several biotechnology companies such as Celgene, and Peregrine Pharmaceuticals About Medisafe 1 Technologies Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient. Forward-Looking Statements This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.
|
Disclaimers
Neither HotShot Stocks Corp nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Hot Shot Stocks Corp, licensed by HotShot Stocks from Information Providers, or gathered by HotShot Stocks from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.
NEITHER HOTSHOT STOCKS CORP NOR THE INFORMATION POVIDERS SHALL HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF THE INFORMATION OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON THE INFORMATION OR "HOTSHOTSTOCKS.COM," OR FOR INTERRUPTION OF ANY DATA, INFORMATION, OR ANY OTHER ASPECT OF "HOTSHOTSTOCKS.COM." THE PAST PERFORMANCE OF A MUTUAL FUND, STOCK, OR INVESTMENT STRATEGY CANNOT GUARANTEE ITS FUTURE PERFORMANCE.
NEITHER HOTSHOT STOCKS CORP. NOR ITS INFORMATION PROVIDERS MAKE ANY REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, SOFTWARE, PRODUCTS, OR SERVICES CONTAINED IN "HOTSHOTSTOCKS.COM" ALL SUCH INFORMATION, SOFTWARE, PRODUCTS, AND SERVICES ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.
If you have received this email in error, or you wish to no longer be on the HotShot Stocks mailing list, please click here, type in the active email address and the word UNSUBSCRIBE.
Disclosures: http://www.hotshotstocks.com are not registered investment advisers or broker/dealers. http://www.hotshotstocks.com makes no recommendation that the purchase of securities of companies profiled in this Web site is suitable or advisable for any person or that an investment such securities will be profitable. Profiles is a special advertising section presented by HotShotStocks.com. All material listed within http://www.hotshotstocks.com, http://www.hotshotstocks.com/profiles.htm, http://www.hotshotstocks.com/profiles-details_MFTH.htm. ("Profiles") was based upon information supplied by the company or from other sources believed to be reliable. The information contained Profiles is not guaranteed by Profiles to be accurate and should not considered to be all-inclusive. The companies discussed on Profiles except for those companies that appear on the URL http://HotShotStocks.com have not approved the statements made herein. Any discussions and pages contain forward looking statements that involve risks and uncertainties. A company's actual results could differ materially from those described in any forward - looking statements or announcements discussed on Profiles. All material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Profiles is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst, or underwriter. Companies profiled at URL http://www.hotshotstocks.com are ineligiable for recommendations on URL http://www.hotshotstocks.com for 90 days following final disposition of any compenstation. "Fair Disclosure". We expect to be compensated $500.00 by a third party.